Hannah T Ryles

Hannah T Ryles

University of Pennsylvania - Philadelphia / United States
Medical and Health Sciences / Obstetrics and Gynecology
AD Scientific Index ID: 1778312
person_outline Hannah T Ryles's MOST POPULAR ARTICLES
1-) ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaSC Bresler, DA Weiser, PJ Huwe, JH Park, K Krytska, H Ryles, ...Cancer cell 26 (5), 682-694, 20143302014
2-) The ALK/ROS1 inhibitor PF-06463922 overcomes primary resistance to crizotinib in ALK-driven neuroblastomaNR Infarinato, JH Park, K Krytska, HT Ryles, R Sano, KM Szigety, Y Li, ...Cancer discovery 6 (1), 96-107, 20161592016
3-) Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against NeuroblastomaAC Wood, K Krytska, HT Ryles, NR Infarinato, R Sano, TD Hansel, ...Clinical Cancer Research 23 (11), 2856-2868, 20171192017
4-) Crizotinib synergizes with chemotherapy in preclinical models of neuroblastomaK Krytska, HT Ryles, R Sano, P Raman, NR Infarinato, TD Hansel, ...Clinical Cancer Research 22 (4), 948-960, 20161192016
5-) Is nocturia associated with detrusor underactivity?HT Ryles, SA Sansone, PJ Levin, UU Andy, HS Harvie, LA AryaUrogynecology 27 (9), e639-e644, 202172021